An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to message these accounts privately for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share comparison photos, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in users administering products of unknown origin.
Several experts stated the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer laws, potentially leading to fines, prosecution or prison.
Platform Reaction and Material Removal
Based on the social media company, the platform has removed problematic material and banned associated keywords and query recommendations. The company said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.
Online Trading Activities
Research also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of members, populated with images of weight loss, glowing reviews and detailed instructions for mixing or injecting at residence.
Within moments of entering one group, a seller shared WhatsApp details, where most transactions take place. The seller sent an instruction manual and promised shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.
Item Details and Costs
Within these groups, posts display dark colored packages with postal service labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When questioned how long a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service said it regularly monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.
Her staff has previously encountered individuals injured by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose users to potentially serious medical dangers”.
